Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Robot-Assisted Closed Reduction and Internal Fixation for Extra-Articular Distal Tibial Fractures

28 de julio de 2026 actualizado por: Beijing Jishuitan Hospital

Key Technology Research and Development for Intelligent Minimally Invasive Precision Treatment of Fractures (Sub-project 4: A Randomized Controlled Trial of Robot-Assisted Closed Reduction and Internal Fixation for Distal Tibial Fractures)

This study aims to evaluate the clinical efficacy and safety of an intelligent fracture reduction robot system in treating extra-articular distal tibial fractures. Traditional manual bone setting depends heavily on a surgeon's experience, which can sometimes lead to inconsistent alignment and increased radiation exposure. This clinical trial compares robot-assisted closed reduction against the traditional surgeon-led method. The primary goal is to determine if the robotic system improves the rate of accurate fracture alignment (excellent and good reduction rate) and helps patients recover better.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Chunpeng Zhao, MD / Chief Physician
  • Número de teléfono: +86 18610012704
  • Correo electrónico: zcpllza2008@163.com

Ubicaciones de estudio

    • Beijing Municipality
      • Beijing, Beijing Municipality, Porcelana, 100035
        • Reclutamiento
        • Beijing Jishuitan Hospital
        • Contacto:
          • Chunpeng Zhao, MD / Chief Physician
          • Número de teléfono: +86 18610012704
          • Correo electrónico: zcpllza2008@163.com
      • Beijing, Beijing Municipality, Porcelana, 100035
        • Reclutamiento
        • Aerospace Center Hospital
        • Contacto:
          • Yonghui Liang, MD / Chief Physician

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Unilateral, acute, closed distal tibial fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 43-A)
  • Time from injury to surgery < 21 days
  • Able to walk independently before injury (assistive devices allowed)

Exclusion Criteria:

  • Open fractures or multiple severe traumas requiring priority treatment
  • Asymmetrical lower extremities, or prior malunion of the ipsilateral tibia, or pre-existing deformities significantly affecting rotation/length evaluation
  • Ipsilateral fractures combined with other sites
  • Pathological fractures (tumor/metabolic)
  • Prior complex implants in place or previous surgeries significantly affecting evaluation
  • Active infection or severe systemic medical contraindications (unable to tolerate anesthesia/surgery)
  • Cognitive impairment, poor compliance, pregnancy, or lactation
  • Poor local skin conditions (e.g., obvious blisters, severe soft tissue injury)
  • Deemed unsuitable by the investigator (e.g., unable to follow up as planned) or refused randomization/enrollment

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Robot-Assisted Group
The patient undergoes automated or human-robot collaborative closed fracture reduction powered by an intelligent robotic system. The system integrates deep-learning-based bone segmentation, automatic reduction planning, and a self-adaptive 2D-3D image registration framework to achieve sub-millimeter positioning feedback and force-position collaborative security gates. Following successful reduction, the fracture is fixed with a distal tibial locking plate via the minimally invasive percutaneous plate osteosynthesis (MIPO) technique.
Comparador activo: Traditional Group
The patient undergoes conventional closed or open fracture reduction performed entirely by the surgical team based on traditional clinical experience under ordinary C-arm fluoroscopic guidance. Internal fixation is achieved using standard distal tibial locking plates or intramedullary nails according to the surgeon's choice and standard of care.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Rate of Excellent or Good Closed Fracture Reduction Assessed by Postoperative Low-Dose CT-Based 3D Quantitative Reduction Grading Criteria
Periodo de tiempo: From completion of surgery to postoperative low-dose CT assessment, assessed up to 2 weeks after surgery

The percentage of patients achieving "Excellent" or "Good" anatomical closed reduction. Reduction quality is measured on post-op CT via RadiAnt DICOM Viewer and 3D Slicer based on the worst-performing of 3 dimensions:

  1. Separation/shortening displacement: Excellent (≤3mm), Good (>3-5mm), Fair (>5-10mm), Poor (>10mm).
  2. Angulation deformity: Excellent (≤3°), Good (>3-5°), Fair (>5-10°), Poor (>10°).
  3. Rotational deformity: Excellent (≤3°), Good (>3-5°), Fair (>5-10°), Poor (>10°).

The final reduction grade is determined by the lowest category among these parameters, and the primary outcome represents the proportion of patients graded as Excellent or Good.

From completion of surgery to postoperative low-dose CT assessment, assessed up to 2 weeks after surgery

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Total Operation Time Measured in Minutes
Periodo de tiempo: From initial skin incision to completion of skin closure, assessed up to 8 hours
Total operation time will be measured in minutes and defined as the duration from initial skin incision to completion of skin closure.
From initial skin incision to completion of skin closure, assessed up to 8 hours
Number of Intraoperative C-Arm Fluoroscopy Shots
Periodo de tiempo: From initial skin incision to completion of skin closure, assessed up to 8 hours
The number of intraoperative fluoroscopy shots taken using the C-arm during the surgical procedure will be recorded.
From initial skin incision to completion of skin closure, assessed up to 8 hours
Intraoperative Blood Loss Measured in Milliliters
Periodo de tiempo: From initial skin incision to completion of skin closure, assessed up to 8 hours
The estimated total volume of blood loss during the surgical procedure will be recorded in milliliters.
From initial skin incision to completion of skin closure, assessed up to 8 hours
Length of Hospital Stay Measured in Days
Periodo de tiempo: From hospital admission to hospital discharge, assessed up to 30 days
The length of hospital stay will be recorded in days from admission to hospital discharge.
From hospital admission to hospital discharge, assessed up to 30 days
Robot-Assisted Reduction Planning and Execution Time Measured in Minutes in the Experimental Group
Periodo de tiempo: From initial skin incision to completion of the reduction maneuver, assessed up to 8 hours
For participants assigned to the experimental group, the robot-assisted reduction planning and execution time will be recorded in minutes. This time is defined as the duration from completion of robotic arm setup to completion of the reduction maneuver.
From initial skin incision to completion of the reduction maneuver, assessed up to 8 hours
Time to Radiographic Fracture Union Assessed by Standard X-Ray
Periodo de tiempo: From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
Time to radiographic fracture union will be measured in weeks using standard anteroposterior and lateral X-rays. Fracture union is defined as cortical bridging in at least 3 of 4 cortices with no significant pain during weight-bearing. Low-dose CT may be used to confirm fracture union in uncertain cases.
From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
Radiographic Fracture Union Rate Assessed by Standard X-Ray
Periodo de tiempo: From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
The percentage of participants achieving radiographic fracture union will be assessed using standard anteroposterior and lateral X-rays. Low-dose CT may be used to confirm fracture union in uncertain cases.
From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
Foot and Ankle Ability Measure-Activities of Daily Living Score
Periodo de tiempo: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
The Foot and Ankle Ability Measure-Activities of Daily Living (FAAM-ADL) score is used to assess the functional status of patients with foot and ankle disorders. The subscale consists of 21 items, with a maximum total raw score of 84. The scores are converted into a percentage score ranging from 0% to 100%, where a higher score indicates a higher level of functional ability.
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
Lower Extremity Functional Scale Score
Periodo de tiempo: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
The Lower Extremity Functional Scale (LEFS) is used to evaluate the patient's lower extremity function and ability to perform everyday tasks. The scale contains 20 items with a total raw score ranging from 0 to 80, where a higher score represents better functional status.
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
EuroQol 5-Dimension 5-Level Health Index
Periodo de tiempo: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
The EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire evaluates health-related quality of life across 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The raw response is converted into a health state index score typically ranging from 0 (representing death) to 1 (representing perfect health), with higher scores reflecting better overall quality of life.
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
EuroQol Visual Analogue Scale Score
Periodo de tiempo: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
The EuroQol Visual Analogue Scale (EQ VAS) provides a quantitative measure of the patient's self-rated overall health status. The score is recorded on a visual scale ranging from 0 to 100, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state.
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
Incidence of Intraoperative Complications
Periodo de tiempo: From initial skin incision to completion of skin closure, assessed up to 8 hours
The percentage of participants experiencing intraoperative complications, including neurovascular injury, cortical perforation, abnormal bleeding, device failure, registration failure requiring manual takeover or change of reduction strategy, will be recorded.
From initial skin incision to completion of skin closure, assessed up to 8 hours
Incidence of Postoperative Complications
Periodo de tiempo: From completion of surgery to postoperative complication assessment, assessed up to 12 months after surgery
The percentage of participants experiencing postoperative complications, including wound problems or infection, thrombotic events, internal fixation failure, or loss of reduction, will be recorded.
From completion of surgery to postoperative complication assessment, assessed up to 12 months after surgery
Incidence of Reoperation
Periodo de tiempo: From completion of surgery to reoperation assessment, assessed up to 12 months after surgery
The percentage of participants requiring reoperation after the index surgery will be recorded.
From completion of surgery to reoperation assessment, assessed up to 12 months after surgery

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de julio de 2026

Finalización primaria (Estimado)

31 de diciembre de 2027

Finalización del estudio (Estimado)

31 de diciembre de 2028

Fechas de registro del estudio

Enviado por primera vez

29 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

28 de julio de 2026

Publicado por primera vez (Actual)

29 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

29 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • Ji-Lun [K2026] No. [190]-00

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir